Journal ArticleOPEN ACCESS

Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages

  • Wang Q
  • Guo Y
  • Ho J
  • et al.
New England Journal of Medicine (2024) 391(19) 1863-1864
DOI: 10.1056/nejmc2410203
26Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

SARS-CoV-2 continues to evolve under immunologic pressure. A synthesized version of pemivibart, an anti–SARS-CoV-2 monoclonal antibody with recent emergency-use authorization, showed mixed activity...

Cite

CITATION STYLE

APA

Wang, Q., Guo, Y., Ho, J., & Ho, D. D. (2024). Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages. New England Journal of Medicine, 391(19), 1863–1864. https://doi.org/10.1056/nejmc2410203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free